[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100633803":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":15,"locations":7,"responsibleParty":21,"collaborators":7,"id":23,"slug":24,"hasResults":25,"nctId":26,"briefTitle":27,"officialTitle":27,"acronym":7,"eligibilityCriteria":28,"healthyVolunteers":25,"sex":29,"minAge":7,"maxAge":7,"enrollmentInfo":7,"targetDuration":7,"studyType":30,"phases":7,"briefSummary":31,"conditions":32,"keywords":7,"overallStatus":34,"whyStopped":7,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":7,"completionDateStruct":7,"leadSponsor":39,"locationsCount":7},{"fullName":5,"class":6},"Alterity Therapeutics","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":13},"DRUG","ATH434","ATH434 tablets",[14],"PBT434",[16],{"name":17,"role":18,"phone":19,"phoneExt":7,"email":20},"Alterity Clinical Trials","CONTACT","888-556-7582","clinicaltrials@alteritytx.com",{"type":22,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100633803","post-trial-access-to-ath434-for-patients-with-multiple-system-atrophy-100633803",false,"NCT07531433","Post-Trial Access to ATH434 for Patients With Multiple System Atrophy","Inclusion Criteria:\n\n* Completed Alterity protocol ATH434-201 or ATH434-202\n* Expected to benefit from treatment from treatment with ATH434, in the opinion of the treating physician\n\nExclusion Criteria:\n\n* Discontinued prior ATH434 treatment (ATH434-201 or ATH434-202) for any reason\n* Significant medical or psychiatric condition that may decrease the benefit-risk ratio of participation in this program to an unacceptable level, as per the treating physician's opinion","ALL","EXPANDED_ACCESS","This multicenter post-trial access program is designed to provide ATH434 orally BID to eligible patients who completed Phase 2 studies ATH434-201 or ATH434-202, and who may benefit from this treatment according to the evaluation by their treating physicians.",[33],"Multiple System Atrophy","AVAILABLE","2026-04-09",{"date":37,"type":38},"2026-04-15","ACTUAL",{"name":5,"class":6}]